FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/05/086983 [Registered on: 15/05/2025] Trial Registered Prospectively
Last Modified On: 13/05/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To evaluate the efficacy of Eranda taila Matrabasti with Tamsulosin tablet in the management of vatashtheela (mutraghata) w.s.r to benign prostatic hyperplasia.  
Scientific Title of Study   Randomized controlled clinical study of Eranda taila Matrabasti with Tamsulosin tablet in the management of vatashtheela (mutraghata) w.s.r. to benign prostatic hyperplasia. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kiran Uttam Sirsat  
Designation  PG scholer M S Shalyatantra  
Affiliation  Matoshri Asarabai Darade Ayurved College Babhulgaon Yeola 
Address  Matoshri Asarabai Darade Ayurved Hospital,Ground floor,OPD NO 04/05,Matoshri Asarabai Darade Ayurved college,SND Campus,Babhulgaon,Tal-Yeola,Dist-Nashik
Nil
Nashik
MAHARASHTRA
423401
India 
Phone  7385349279  
Fax    
Email  sirsat230@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Manoj L Sonaje 
Designation  HOD and Professor,Department of Shalyatantra  
Affiliation  Matoshri Asarabai Darade Ayurved College Babhulgaon Yeola 
Address  Matoshri Asarabai Darade Ayurved Hospital,Ground floor,OPD NO 04/05,Matoshri Asarabai Darade Ayurved college,SND Campus,Babhulgaon,Tal-Yeola,Dist-Nashik
Nil
Nashik
MAHARASHTRA
423401
India 
Phone  9423932283  
Fax    
Email  manojsonaje@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kiran Uttam Sirsat  
Designation  PG scholer M S Shalyatantra  
Affiliation  Matoshri Asarabai Darade Ayurved College Babhulgaon Yeola 
Address  Matoshri Asarabai Darade Ayurved Hospital,Ground floor,OPD NO 04/05,Matoshri Asarabai Darade Ayurved college,SND Campus,Babhulgaon,Tal-Yeola,Dist-Nashik
Nil
Nashik
MAHARASHTRA
423401
India 
Phone  7385349279  
Fax    
Email  sirsat230@gmail.com  
 
Source of Monetary or Material Support  
Matoshri Asarabai Darade Ayurved College Affiliated With Matoshri Asarabai Darade Hospital,SND Campus,Babhulgaon,Yeola-423401  
 
Primary Sponsor  
Name  Matoshri Asarabai Darade Ayurved College,Babhulgaon,Yeola 
Address  Department Of shalyatantra,Ground Floor,OPD NO 04-05, Matoshri Asarabai Darade Ayurved College And Matoshri Asarabai Darade Hospital,SND Campus,Babhulgaon,Yeola-423401 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Kiran Uttam Sirsat  Matoshri Asarabai Darade Hospital,Babhulgaon,Yeola  Department of shalyatantra,Ground floor,OPD no 04-05,Matoshri Asarabai Darade Ayurved college and Matoshri Asarabai Darade Hospital,SND Campus,Babhulgaon,Yeola 423401
Nashik
MAHARASHTRA 
07385349279

sirsat230@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Matoshri Asarabai Darade Ayurved College,Babhulgaon,Yeola  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N401||Benign prostatic hyperplasia withlower urinary tract symptoms. Ayurveda Condition: VATASHTHILA,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-mAtrAbastiH, मात्राबस्तिः (Procedure Reference: Chakradatta chikitsa 33 shloka 1, Procedure details: Matrabasti with Eranda taila will be given for 7 days.60 ml of lukewarm Eranda taila loaded in an enema syringe. A sterile Red rubber catheter oleated with oil was attached to enema syringe.The red rubber catheter passed through the anus of the patient up to a length of 4 inches and the drug was administered.Matrabasti will be given once a day.)
(1) Medicine Name: Eranda Taila , Reference: Bhavprakash Tailvarga 6 shloka 22-23-24-25, Route: Rectal, Dosage Form: Taila, Dose: 60(ml), Frequency: od, Duration: 7 Days
2Comparator Arm (Non Ayurveda)-TAB TAMSULOSINTamsulosin is Alpha-1 adrenergic agent which inhibit smooth muscle contraction of prostate.They reduce bladder neck resistance so as to improve the urine flow. Medicine Name:Tab Tamsulosin, Reference:Smith and Tanaghos General Urology,19th Edition,Chapter No.38,Page No.597, Route:oral, Dosage Form:Tablet, Dose:0.4 mg, Frequency:Once a day (At Night), Duration:7 Days
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  70.00 Year(s)
Gender  Male 
Details  1.Age group between 40 yrs to 70 yrs.
2.Classical sign and symptoms of Mutraghata (BPH).
3.USG of prostate suggestive of increased size and weight.
4.Significant post voidal urine of greater than 90CC upto 200 CC.  
 
ExclusionCriteria 
Details  1.Age below 40 yrs and above 70 yrs.
2.Acute retention of urine.
3.Severe urinary calculi with significant obstructive uropathy.
5.Renal failure.
6.Systemic diseases like HIV, Hepatitis, T2DM.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The parameters will be noted down before and after treatment.
The patient will be diagnosed based on symptoms of Vatashteela (Mutraghata) explained in Ayurvdic and Modern texts.
1.Incomplete Emptying
2.Frequency
3.Intermittency
4.Urgency
5.Weak Stream
6.Straining
7.Nocturia 
1st,14th,21st,28th 
 
Secondary Outcome  
Outcome  TimePoints 
NIL  NIL 
 
Target Sample Size   Total Sample Size="64"
Sample Size from India="64" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   24/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Acharya Sushruta The father of indian surgery has described 12 types of Mutraghata in uttartantra and also described the management of mutraghata which includes Basti,Uttarbasti,Virechan etc. Chikitsa.
As ayurveda is an ancient science of medicine, had explained about the disease of urinary tract system i.e Mutraghata srotas under the topic of Mutrakricchara,Mutraghata, ashmari.
Acharya Charaka has explained, an Apan Vayu is situated in the space between rectum and urinary bladder which produced a hard swelling like a stone,which is mobile,elevated ,and glandular . Which obstruct the passage of urine and feaces and produce symptoms like sanga.
Prostate gland is the part of male reproductive system, it is of walnut size and weight about 1 ounce i.e 24 grams.Prostate is present below the urinary bladder and infront of rectum. it goes around the tube called urethra which carries urine from bladder out through penis.
BPH is enlargement of medial lobe of prostate is responsible for obstruction of urethra. This lobe upwards into the bladder.
Medicines like ALPHA BLOCKERS i.e Tamsulosin is effective in benign prostatic hyperplasia. Tamsulosin works by relaxing the muscle around the bladder and prostate gland so urine is passed more easily. This helps empty the bladder completely and reduces the need to pass urine frequently or urgently in BPH.
 
Close